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ABsTRACT This article analyzes the century-long persistence of Chagas disease in 
Argentina, taking into account the different dimensions (the biological, the informational, 
the political, the professional and the technical) that take part in the disease’s defi nition. 
Emphasis is placed on the identifi cation and discussion of fundamental tensions that 
have marked the history of the disease, with the intention of discussing the concrete 
conditioning factors that have, on the one hand, permitted the continuity of Chagas as 
a subject of political consideration, but on the other have made it impossible to reach a 
situation of defi nitive control over the disease.
Key WORDs Chagas Disease; Knowledge; History; Policies.
ResUMeN El artículo analiza la persistencia de la enfermedad de Chagas en la Argentina 
durante más de un siglo, prestando atención a las diferentes dimensiones (biológica, de 
conocimiento, política, profesional y técnica) que participan en su defi nición. Se pone 
el acento en la identifi cación y discusión de algunas de las tensiones fundamentales que 
han marcado la historia de la enfermedad, con la intención de discutir cuáles han sido 
los condicionamientos concretos que han marcado, por un lado, la continuidad de la 
enfermedad dentro de la consideración política pero, al mismo tiempo, la imposibilidad 
de alcanzar una situación de control defi nitivo.
PAlABRAs ClAves Enfermedad de Chagas; Conocimiento; Historia; Políticas.
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INTRODUCTION
Chagas disease, also referred to as American 
trypanosomiasis, celebrated a century of existence 
in 2009, from the day Carlos Chagas announced 
the discovery of Trypanosoma cruzi (the caus-
ative parasite), the insect vector (triatomine bug 
in English, called barbeiro in Brazil and vinchuca 
in Argentina) and a set of characteristic clinical 
symptoms. This announcement occurred in the 
Brazil of the early 20th century, a time when the 
control of infectious diseases appeared a sure 
ticket to order and progress (1,2). 
Throughout the 20th century, Chagas disease 
became a symbol of the huge portion of the pop-
ulation of Latin America living in conditions of 
material poverty, especially in rural areas, with 
little information or access to basic health and 
sanitation services. This situation is currently re-
flected in official figures showing 8 million people 
infected with the parasite – who are susceptible to 
suffering from the chronic cardiac and digestive 
conditions characteristic of the disease – and 100 
million people at risk of getting infected, as well 
as 56,000 new cases annually and 12,000 deaths 
per year (3).   
For over half a century, Chagas has been 
recognized as a major public health problem, at 
least discursively, both in Argentina and the rest 
of Latin America, and several intervention pro-
grams have been developed in order to control 
the disease. These programs have included a va-
riety of actions, such as the elimination of vectors, 
the promotion of research in different areas of 
knowledge, the regulation of blood transfusions, 
education campaigns, and housing improvement. 
Nevertheless, the antiparasitic treatments in use 
today are the same that have been available since 
the mid-1970s, and the other treatments used for 
cardiac or digestive symptoms are not specific to 
the afflictions derived from Chagas disease. 
How can we understand the persistence of 
the disease throughout the decades, in a context 
in which technical resources are available for its 
control and the political initiative to allocate funds 
to fight this disease exists?
This article seeks to formulate a response 
to this question based on the idea that Chagas 
disease has been marked by a fundamental 
tension between recognition and neglect that has 
influenced its history. On the one hand, we find 
the existence of actions that have emphasized 
the importance of Chagas as a social problem, 
placing it in the field of politics and in the col-
lective consciousness as an issue requiring inter-
vention. On the other, we observe actions that 
have tended to invisibilize the problem in po-
litical, medical and symbolic terms. The results 
of this tension are prolonged actions aimed at 
controlling the disease in different ways, but also 
the impossibility of definitively achieving this 
objective. In other words, Chagas disease has 
neither been so neglected as to disappear from 
the political agenda nor so present as to put a 
permanent end to its reproduction cycle.  
It is necessary to explore this tension and an-
alyze the way in which it is inscribed within the 
rationalities, beliefs and interests of the different 
actors involved in the definition of the disease – 
politicians, physicians, researchers, the infected 
and the ill – in order to avoid replicating the two 
approaches typically used to explain the “failure” 
to control Chagas. The first of these approaches, 
which is eminently scientistic and technocratic, 
emphasizes the lack of development of adequate 
means of disease control, such as vaccines, more 
effective antiparasitic drugs or insecticides with 
greater residual action. From this standpoint, ad-
vances in science and technology are what will 
eventually enable us to put an end to the problem 
(a). The second explanation tends to take a political 
and commercialist perspective: the persistence of 
Chagas is related to lack of political interest be-
cause it is a disease that affects people who are 
poor – and who are thus subjects unable to gen-
erate earnings and profits. Therefore, the only way 
to solve the problem is to define political priorities 
with non-mercantile criteria.  
When we take a closer look at the disease, 
we see that these simplistic approaches do not 
reflect its reality. Chagas is a complex entity 
conditioned by the biological processes in-
volved as well as the professional, economic, 
political, cultural and institutional interests at 
stake in the definition of the disease and, above 
all, in the way to take action and intervene. As 
a result of this complexity, the trajectory of the 
disease contains a series of paradoxes that have 
marked its prolonged history: 
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a. A milestone in the history of science, and yet an 
entity which tends to be invisible within current 
medical practice.
b. A “neglected disease,” and yet a constant in the 
public policy agenda.
c. The achievement of relative success in terms 
of fighting the vector, and yet the persistence 
of a reality that contributes to the vector’s 
development.
d. The disease with the largest affected population, 
and yet the least visible social group in terms of 
identification and social organization. 
e. A rural disease, and yet an urban public health 
problem and a threat to developed countries.
f. An important symbol of the scientific community’s 
commitment to social reality, and yet a sign of the 
scant concrete incidence of science in people’s 
living conditions.
g. A field of knowledge with major advances, and 
yet with drugs approximately 40 years old and 
with limited effectiveness. 
These paradoxes will be analyzed through 
three fundamental nodes in the definition of 
Chagas, which may enable us to understand, ac-
cording to the particularities of the disease (5), 
the way in which the tension between visibility 
and invisibility has expressed itself historically, 
always as a result of a mutual conditioning among 
the different technical, biological, informational, 
professional and political dimensions. The first of 
these nodes refers to the definition of the disease 
according to its biomedical aspects, both in its 
characterization and in the administration of treat-
ments. The second makes reference to the way 
in which the disease has become the object of 
different types of public policies, with the con-
sequent implementation of different plans of 
intervention. The third refers to the disease as a 
structuring framework of identities and relations, 
which condition and preform the identities of the 
affected individuals.
DIsCOveRy, ReDefINITION AND 
DIsAPPeARANCe Of The DIseAse 
Diseases differ from the rest of the social 
problems in that their definition uses as a frame 
of reference one or many of the biological events 
which, through the expert views of scientific and 
professional knowledge, condition how the disease 
is conceived. This obligates us consider that the 
very definition of those events – objective in ap-
pearance – is also the result of social processes in 
which it is possible to find elements that condition 
how the disease is finally constituted as a social 
problem.
In the case of Chagas, the process by which 
the disease became a stable medical entity is 
particularly rich for exploring the tension be-
tween visibility and invisibility, as the profound 
changes it has undergone at the cognitive level 
throughout its history have made the demarcation 
of the problem unstable. Chagas disease made a 
striking appearance in the medical and scientific 
world at the beginning of the 20th century. Its ap-
pearance is recognized as an exceptional case in 
the history of traditional science and medicine, 
given that in a very short period of time a single 
person was able discover all the components of 
a new infectious disease: the causal agent (Try-
panosoma cruzi), the vector (vinchucha, barbeiro 
or triatomine bug) and the clinical profile of the 
disease.
The characterization of the disease first made 
by Chagas in his works stated that, in recent in-
fections, the acute stage “almost always results in 
death […], especially in the case of children under 
6 months of age,” whereas in children “over 1 year 
of age, it does not always prove fatal; many in-
fected individuals pass on to the chronic stage” (6 
p.263). Undoubtedly, the chronic stage (b), related 
to the effects of the infection in the long term, was 
what aroused the greatest interest in the medical 
community and public health policymakers. In 
this stage of the disease, Chagas asserted, the 
parasite caused serious functional perturbations in 
the thyroid gland and nervous system, thus sug-
gesting an explanation for the health situation of 
a region characterized by a high rate of goiter; a 
vast number of cases of profound anemia with 
great organic decline, causing developmental 
delays in children and infantilism in adults; no-
table deficiencies in the nervous system; and, 
associated with these deficiencies, speech and 
communication impairments along with a large 
number of cases of imbecility (7). Chagas further 
stated that “in some cases […], especially in adults, 
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perturbations of the cardiac rhythm are very fre-
quent” (6 p.265).
The reverberations of Chagas’s announcement 
lay not only in the scientific ability to identify a 
new species but also in the capacity of those asser-
tions to propose a biologically-based explanation 
for a social situation of poverty, deprivation, and 
underdevelopment, via the identification of causes 
invisible to most people. With this demarcation, the 
experienced eyes of a scientist trained at the fore-
front of the protozoology of the time, with access 
to a scientific laboratory and with a prestige con-
solidated in previous successful public health cam-
paigns (c), offered a new lens for understanding the 
decades-long misfortune of millions of people scat-
tered across the immense region of Brazil set away 
from the coast. And, from this point of departure, 
the articulation of a political movement – led to a 
great extent by Chagas – that proposed the “saniti-
zation of Brazil” through the eradication of certain 
agents hazardous to public health, with scientific 
research spearheading these measures (9,10).
Nevertheless, Chagas’s description in the first 
years of the disease then became the subject of long-
standing professional debates which questioned the 
seriousness of the disease and marked the transition 
from a first stage of wide recognition to another de-
fined by uncertainty, controversies and, definitively, 
neglect. In particular, the difficulty of demonstrating 
cases that confirmed the magnitude of the disease 
(d) and the continued questioning of the relationship 
between the parasite and goiter radically rocked the 
foundations of what had constituted the disease as a 
public health problem (e).
Many years elapsed before reaching the 
current definition of the disease as characterized 
by cardiac and digestive conditions. From the 
early 1920s to the late 1930s, research regarding 
the disease focused on defining the true effects 
of the parasite, the way to identify infected indi-
viduals, and the possibility of distinguishing a 
specific clinical profile. This task took on special 
significance in the studies carried out by Sal-
vador Mazza in the Study Mission on Regional 
Pathologies of the North [Misión de Estudios de 
Patología Regional del Norte] in the mid-1920s 
(13,14). At a time when it was believed that the 
disease did not exist in Argentina, Mazza explored 
the matter in the context of a program of study 
on regional pathologies in the north of Argentina, 
promoting and articulating different studies that 
looked in to many of Chagas’s initial concerns (f).
In that context, the disease increased in im-
portance as the number of “acute cases” compiled 
grew. This growth was favored by the discovery of 
“Romaña’s sign” – an inflammation of the eyelid 
caused by the bite of the vinchuca – which al-
lowed the disease to be identified by non-expert 
physicians (2,9,16,17,18). By the late 1930s, the 
disease began to be considered a public health 
problem of great importance within the scientific-
medical field, thanks to the accumulation of cer-
tified cases and the intensive activities of scientific 
communication carried out by Mazza and his 
collaborators.  
Nevertheless, despite the resurgence of 
Chagas as a subject of professional interest, the 
definition of the clinical profile of the disease 
remained erratic. Goiter and nervous conditions 
lost importance in the definition of the clinical 
profile, while the cardiac form of the disease, 
starting in the 1930s, became the main interest 
of research studies, both in Argentina and Brazil. 
Chagas and his disciples maintained, within a 
small group, their interest in the issue in Brazil: 
“The cause-and-effect relationships, if indeed 
they exist, between goiter and infection by Try-
panosoma cruzi are debatable. […] It is an open 
question that merits further studies and insights” 
[“Discutíveis são as relações de causa e efeito, 
acaso existentes, entre o bócio e a infecção pelo 
Trypanosoma cruzi. [...] É uma questão aberta, 
a merecer estudo e perspicácia.”] (19 p.63). Not 
until the 1950s did Chagas cardiopathy become 
the object of systematic research for cardiologists, 
who defined within the framework of that spe-
cialty both the specific characteristics of Chagas 
in relation to other cardiac diseases and the di-
agnosis of “chronic Chagas cardiomyopathy” via 
electrocardiogram (g).  
With this description of the cardiac profile, 
the disease broke the random barrier separating 
the infected from the ill: having Chagas disease 
would no longer mean simply testing positive 
in a biochemical test for Trypanosoma cruzi in-
fection, but also developing a specific condition, 
identified by the instruments and knowledge of 
cardiology. Therefore, its importance as a public 
health problem was based on a specific number of 
individuals with a condition impairing their work 
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ability, which translated into the suffering of those 
with the condition and into measurable losses in 
the country’s production capacity due to the re-
duction in the workforce. 
This new description implied a reconfigu-
ration in the meaning of the disease, in that a spe-
cific medical specialty – cardiology – emerged as 
the area of legitimate knowledge and professional 
practice for defining sick individuals, the symptoms 
of the disease and the gravity of those symptoms. 
This also meant a relocation of the problem spa-
tially, in that public health care centers in the city 
of Buenos Aires began to diagnose chronic cases 
of Chagas disease among their patients, rural mi-
grants who moved to the city to work. 
Broadly speaking, over the last decades, the 
visibility of the disease within the medical world 
has been maintained within this articulation of 
knowledge and practices. This persistence can 
also be observed in the professional world and in 
the heart of health institutions: the formation of a 
community of cardiologists specialized in Chagas 
disease and the creation of Chagas services in dif-
ferent hospitals are tangible indications that the 
issue has maintained certain relevance within the 
health field.
Nonetheless, this visibility is opposed by 
other tendencies that threaten the recognition of 
Chagas as an autonomous morbid entity. Indeed, 
it is possible to observe at least two phenomena in 
the last years that tend towards the invisibilization 
of the disease. Firstly, the advances in cardiology 
increasingly lead, on the part of the cardiologists 
themselves, to the treatment of the disease ac-
cording to the patients’ coronary symptoms, dis-
regarding that such deficiencies are caused by a 
parasitic infection. Whether through drugs, pace-
makers or micro-defibrillators, Chagas cardiomy-
opathy receives specific treatments that tend to 
reverse those symptoms, in the same way as with 
any other cardiac condition. In other words, it is 
not necessary to be a specialist in a particular area 
in order to treat Chagas disease.  
This phenomenon has its impact in the or-
ganization of the health profession. Whether 
due to the lack of intellectual and professional 
challenges or the scant economic possibilities 
it offers, Chagas does not appear an attractive 
option within the professional specialties. The 
communities of experts maintain their same 
senior members but have little generational 
turnover. Therefore, although it may be recog-
nized within public health discourses as an im-
portant health problem, Chagas disease tends 
to be invisibilized within current professional 
medical practice, and is diluted within proce-
dures that are not specific to its etiology. 
Only in the last years have initiatives been im-
plemented to reinforce the importance of treating 
the parasitic etiology of the Chagas-originated 
cardiac conditions, suggesting the administration 
of antiparasitic treatment to the chronically ill. This 
approach has not escaped controversy (20) as at 
least two opposing views exist without there being 
conclusive evidence on the subject. On the one 
hand are those who argue that once the parasitic 
infection has persisted over a certain number of 
years, the antiparasitic treatment is ineffective and 
its administration is no longer justified, as it is pro-
vides no benefit to patients and exposes them to 
the harmful side effects of the drugs prescribed. 
However, others argue that the treatment is ben-
eficial even for the chronically ill, although the 
negativization of the infection can only be demon-
strated in serological analyses after several years. 
The second perspective has gained ground in 
recent years and treatment is now officially recom-
mended in children and adolescents. Regardless 
of how the controversy is finally resolved, it is in-
teresting to note that behind the scientific debate 
lie two different ways of delineating the disease 
from a medical standpoint: one that considers only 
those with cardiac or gastrointestinal conditions 
(who make up only 30% of all those infected) 
through general treatments used for similar condi-
tions of different origins, and another that recovers 
the specificity of the disease by attacking its eti-
ology and suggesting intervention in the totality of 
those infected.          
ChAgAs As The OBJeCT Of POlICy: 
BeTWeeN NegleCT AND ReCOgNITION 
Chagas is one of the so-called “neglected” 
diseases. This term has been applied to a group 
of widespread endemic diseases, which mainly 
affect populations of little resources in Latin 
America, Africa and Asia, and cause great losses 
14 ZABAlA JP.
SA
LU
D
 C
O
LE
C
TI
V
A
, B
ue
no
s 
A
ire
s,
 8
(S
up
pl
 1
):S
9-
S2
1,
 N
ov
em
be
r, 
20
12
Universidad Nacional de Lanús | Salud Colectiva | English Edition ISSN 2250-5334 | E-ISSN 1851-8265| ISSN-L 1669-2381
in terms of mortality and morbidity. In particular, 
this term is applied to those diseases that do not 
represent an economic interest to the pharmaceu-
tical industry that would justify the development 
of new drugs. The consequence of this lack of in-
terest is that there is little dynamism in the devel-
opment of modern and more effective treatments, 
as in the case of Chagas.   
This neglect can also be perceived in other 
dimensions such as in the lack of initiatives for 
disease treatment, control or eradication, even 
if the necessary means of preventing or curing 
those diseases exist, frequently at a low cost. 
However, the image transmitted by the term “ne-
glected” should be somewhat attenuated, at least 
for Argentina. Chagas disease has remained an 
important issue both in the public health agenda 
and in the collective conscious at least since the 
1950s, and is still the object of specific health cam-
paigns carried out by the government and NGOs, 
including vector control, housing improvement, 
and actions to educate and raise awareness in the 
populations in which the disease is still endemic, 
among other measures.  
The official recognition of Chagas as a public 
health problem dates back to the late 1930s. As 
a sign of this interest – recent at that time – on 
the part of the State, Alfredo Sordelli, Director 
of the Carlos G. Malbrán Microbiology Institute 
highlighted the following at the 10th Pan American 
Sanitary Conference in 1938:  
The infestation is spread all over the Argentine 
territory […] Recently there has been such a 
recrudescence that the number of cases 
reaches at least 300. We therefore consider 
the problem worthy of great attention (16 
p.450) [Own translation].  
It was not until the end of the 1940s that 
this recognition assumed greater importance, 
owing to the convergence of three independent 
processes: a) the redefinition of the disease in 
medical and epidemiological terms as a chronic 
and mainly cardiac condition affecting approxi-
mately 1,000,000 people in the country (the 
number of people presumably infected with the 
parasite); b) the availability of Gammexane as the 
primary means of fighting the insect vector; and 
c) a context of public health policies favorable to 
the recognition of and fight against epidemics, em-
bodied principally by the figure of Ramón Carrillo, 
Minister of Health under Peron’s government. 
Therefore, Chagas disease came to be categorized 
as a “national problem” (21) and around it an insti-
tutional apparatus was developed which included 
programs for fighting the vector as well as the 
planning of activities for diagnosis, research, and 
development of alternative treatments.     
The main Chagas intervention policies were 
oriented towards interrupting infection by the 
vector, that is, infection through the bite of the 
vinchuca. These policies manifested themselves 
in different ways throughout the 20th century. 
They were first implemented by the Executive 
Committee for Chagas Disease Research and Pro-
phylaxis [Comité Directivo de Investigaciones y 
Profilaxis de la Enfermedad de Chagas], created 
in 1950 as the first institution officially respon-
sible for fighting the disease, which reported to 
the recently created National Ministry of Health. 
This Committee saw the beginning in Argentina 
of what its director Cecilio Romaña, former col-
league of Salvador Mazza, called “the era of re-
sidual insecticides and [of] the ‘new awareness’ 
awakened by preventive medicine” (22 p.215).
Throughout the years, this institution un-
derwent several transformations. In 1952 it 
became the National Service for the Prophylaxis 
and Fight against Chagas Disease [Servicio Na-
cional de Profilaxis y Lucha contra la Enfermedad 
de Chagas], also headed by Romaña, “in charge 
of the implementation, enforcement and surveil-
lance of the programs created for such purposes” 
(Executive Order 2177 on July 8, 1952). It was in 
this context that the first Chagas disease control 
measures took place, following the technical 
considerations that emerged from Romaña’s ex-
perimental studies. The first insecticide-spraying 
campaigns (with Gammexane) were conducted 
systematically in the provinces of Chaco, La Rioja 
and Catamarca, though these campaigns were 
of an experimental character and the number of 
houses sprayed was quite limited in scope (23). 
In the period succeeding Peron’s gov-
ernment, both institutional transformations and 
medical care for Chagas were constants. The 
consolidation of Chagas disease as a major social 
problem was accompanied by the creation of 
a series of institutions aimed at identifying and 
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measuring the disease and controlling its trans-
mission, not only through the vinchuca but also 
through the establishment of compulsory tests 
for Chagas disease in blood banks and hemo-
therapy services (starting in the early 1960s), and 
subsequently in organ donations. Thus, from the 
mid-1950s onward, the National Service for the 
Prophylaxis and Fight against Chagas Disease, 
created by Health Minister Ramón Carrillo, con-
tinued to develop and transform until becoming 
the current Fatala Chabén National Institute of 
Parasitology, dedicated almost exclusively to the 
diagnosis of Chagas disease. It is also important 
to mention the creation, in the early 1960s, of the 
National Chagas Program, a nationwide structure 
responsible for the fumigation of rural houses 
that has been conducting campaigns to fight the 
vector for decades.  
All of these measures have experienced the 
ups and downs of Argentina’s history, and the sys-
tematicity of their implementation has varied ac-
cording to the interest aroused in the provincial 
authorities of each historical period. Nevertheless, 
it is possible to observe a general decrease in the 
tendency of the transmission of the disease in the 
different modes of transmission. Thus, while in 
1964-1969 10% of the total 18-year-old popu-
lation presented the infection, by the early 1980s 
this percentage had decreased to 5.8% and in 
1993 to 1.9% (24 p.61). Official statistics currently 
show figures similar to these last ones and suggest 
that the average prevalence of infection with Try-
panosoma Cruzi in children under 14 years old is 
approximately 1.5% (25).    
However, these general figures do not ac-
count for the disparity among the different re-
gions. In the case of Argentina, while some 
provinces have certified the interruption of 
vector-borne transmissions, others still show a 
high risk of transmission. 
Chagas and the promotion of research 
Apart from the control of vector-borne and 
transfusion-based transmission, Chagas has re-
ceived considerable attention in policies of scien-
tific research promotion and has thus become the 
object of research for many groups from different 
scientific disciplines.  
This interest on the part of the scientific com-
munity starting in the late 1960s must be under-
stood taking into account a number of factors. 
These include the interest of certain research 
teams in giving social relevance to scientific re-
search; the sustained funding provided by the 
Argentine national government for researching 
the issue; the creation of a World Health Orga-
nization Committee oriented towards the pro-
motion of research on Chagas disease, which 
served as an international source of resources 
starting in the late 1970s; and, as a result of all 
of these elements, the development of a social 
space articulated around the disease, which in-
cluded the participation of several researchers 
specialized in Chagas disease from many Latin 
American countries, especially Brazil and 
Argentina.    
Thus, scientific research became a legitimate 
intervention strategy for the different actors in-
volved in the promotion, production, circulation 
and dissemination of knowledge. This process 
covered a wide range of topics, as the proliferation 
of Chagas-related scientific activity reached all rel-
evant research specialties, from entomology to 
medicine to chemistry; however, the main focus 
was on facilitating the diagnosis of the disease and 
eventually developing a vaccine or appropriate 
antiparasitic drugs. This meant research studies 
primarily concentrated on two issues: the human 
immune response to parasitic infection, in order to 
create a vaccine; and the physiological and meta-
bolic characteristics of the parasite, as well as its 
reactions to different drugs.        
These studies promoted the creation of new 
knowledge about different aspects of the disease 
and permitted major advances in some fields, 
particularly in the adaptation and development 
of new diagnostic methods. Nevertheless, the 
political hope underlying the initial support of 
these research studies never came to fruition, as 
the research did not lead to significant changes 
in treatment methods. In fact, at present the only 
available drug for antiparasitic treatment is benz-
nidazole, which was approved in 1970. Indeed, 
benznidazole (along with nifurtimox, developed 
in 1966) has received considerable attention due 
to its alleged ineffectiveness in the chronic stage 
of the disease and the presence of marked side 
effects in patients.     
16 ZABAlA JP.
SA
LU
D
 C
O
LE
C
TI
V
A
, B
ue
no
s 
A
ire
s,
 8
(S
up
pl
 1
):S
9-
S2
1,
 N
ov
em
be
r, 
20
12
Universidad Nacional de Lanús | Salud Colectiva | English Edition ISSN 2250-5334 | E-ISSN 1851-8265| ISSN-L 1669-2381
PeOPle WITh ChAgAs: sICK, INfeCTeD, 
OR INvIsIBle?
In terms of social practices, a disease is the 
result of a set of actions that arise from the recog-
nition of its specificity. In the case of Chagas, this 
process involves specific actors – the individuals 
with Chagas themselves, the physicians who treat 
them, government officials, and even the rest of 
society that reacts in different ways to the public 
manifestation of the problem – who associate the 
idea of the disease with knowledge that serves as 
a parameter for their actions. Thus, every disease 
plays a social role fundamental in the lives of the 
subjects implicated. From the diagnosis of the 
disease to the taking on of a specific role con-
nected with that disease, the everyday actions of 
the individuals implicated will be affected, one 
way or another, by the expectations and shared 
meanings of what this diagnosis implies.
In Chagas this aspect generates a rather para-
doxical situation, which reflects the tension be-
tween visibility and invisibility constantly at play in 
its definition as a social problem. On the one hand, 
the statistics show that a large number of people 
are affected, to the extent that Chagas disease is 
considered the greatest endemic disease in the 
continent in epidemiological terms; in Argentina 
alone it is estimated that there are 1,600,000 in-
dividuals infected with the parasite. On the other 
hand, the individuals directly affected by Chagas 
have not, throughout the history of the disease, 
constituted themselves into a significant collective 
actor capable of demanding recognition or rights 
or making specific claims, as has been the case in 
other diseases such as HIV/AIDS (h). 
From a formal point of view, recognition 
of the affected individuals – whether in terms of 
“victims,” patients, or subjects of rights – has been 
a historic demand of the medical community and 
has been implicit in every affirmation made about 
the importance of the disease as a public health 
problem, from the incorporation of the disease 
in specialized conferences and its inclusion as a 
disease of obligatory denunciation to the incorpo-
ration of research in routine health controls. 
In more concrete terms, Law 22360 was en-
acted at the beginning of the 1980s, stating that 
preventing and fighting Chagas disease was of 
“national interest,” in order to “favor the control 
and eradication of this endemic disease in the 
country” (26 Art.1). The primary objectives of the 
law were, on the one hand, “to elaborate tech-
nical norms […] for the development, execution, 
evaluation and control of programs in the fight 
against Chagas,” and, on the other hand, “the 
registration, orientation and treatment of the 
sick” (26 Art.2). The first purpose was connected 
to structures already in existence, with the law 
stipulating the need for collaboration among the 
public health authorities of the different districts. 
Regarding the second purpose, however, the law 
introduced some significant changes in the norms, 
establishing compulsory Chagas testing in five key 
areas: upon entry into military service; in blood 
banks and hemotherapy services (both already 
under regulation since the early 1960s); upon 
entry into primary school; in routine health exams 
for pregnant women; and in pre-employment 
medical examinations.
This government initiative could at first seem 
to favor greater recognition of the disease. Never-
theless, in reality, it has clashed with other factors 
that have tended to “invisibilize” the disease in 
the social arena. One of these factors is the ten-
dency of infected individuals to hide their con-
dition, especially when looking for employment, 
due to the discrimination they may face. As the 
disease may imply a disability impairing physical 
activity, those infected with the parasite (even if 
they have not developed any symptoms of the 
disease) may find themselves in less favorable con-
ditions for obtaining employment than those who 
are not infected (27 p.553). Paradoxically, this 
1980s law requiring pre-employment serological 
testing as a means of providing greater visibility to 
the disease, and thereby of facilitating its control, 
has not become a useful tool for the incorporation 
of the disease in the everyday life of the affected 
population. Instead, the law has turned into a new 
obstacle individuals must overcome to avoid dis-
advantages, not related to the physical grievances 
themselves, but rather to the marks that their rural 
past has left in their immune systems.  
The consequences of Law 22360 were so 
paradoxical that in 2007, Law 26281 on Chagas 
Prevention and Control (28) reconsidered this 
unfavorable situation. This new law includes the 
previous statement on the prevention of and fight 
against Chagas disease as an issue of national 
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interest, but focuses on pregnant women, blood or 
organ donors, children, and newborns. Article 5 of 
this new law prohibits testing for Chagas disease in 
pre-employment medical examinations, deeming 
them discriminatory. Moreover, such has been the 
stigmatization of the infected individuals – 70% 
of whom do not develop any illness – that those 
who most advocate developing the awareness and 
involvement of different social actors in the fight 
suggest not making reference to “Chagas disease” 
but rather simply to “Chagas,” thus describing the 
infection as a particular situation but removing part 
of the negative connotation implied by disease (29). 
There are other elements leading to the in-
visibility of Chagas related to the perception of 
affected individuals that the disease is not se-
rious (30). According to Mariana Sanmartino, 
this occurs due to cultural factors, given the 
commonness of the disease, as well as biological 
factors, given the long-term evolution of the 
disease – in the cases in which it does indeed 
develop – and lack of symptoms. It is also worth 
adding the lack of implementation of specific 
protocols by health care professionals.
fINAl RefleCTIONs
Throughout this article I have tried to an-
alyze some tensions that lie within the defi-
nition of Chagas as a public health problem, in 
its biomedical formulation, in the policies aimed 
at controlling it, and in the definition of profes-
sional specialties and social roles associated with 
the disease. This strategy of analysis has a dual 
purpose. The first is to show the complexity of the 
disease as a biological, social, political and cul-
tural entity, considering the specific actors that 
have defined it as such throughout history. The 
second is to specifically analyze the way in which 
the very process of defining how the disease is un-
derstood, how its incidence is measured, and what 
policies are adopted to fight against it establishes 
the limits of what actions are considered possible.
Therefore, irregardless of unfavorable po-
litical situations or periods of neglect, the persis-
tence of Chagas can no longer be seen as the mere 
result of failures, lack of interest or the technical 
ineffectiveness of the available strategies, but the 
predictable and logical result of the actions of the 
different social actors involved.  
In this sense, from the perspective of political 
planning and resource management, it is necessary 
to separate the interest and reaction the disease 
has provoked in the State into different sectoral 
policies that promote specific initiatives within the 
State’s area of incumbence. While at a discursive 
level the eradication or control of the disease still 
seems a distant horizon, this goal must be trans-
lated into concrete actions, as policies should be 
designed for and oriented towards accomplishing 
concrete medium-term goals in a demarcated area 
of action, such as fumigation, control of blood do-
nations or the promotion of scientific knowledge.  
In some cases, the translation of that distant 
horizon of eradication into concrete actions de-
veloped as a result of this political interest comes 
up against structural limitations that go beyond 
the will of the actors involved. This is clearly seen 
in the case of scientific research, which does not 
aim to eradicate Chagas but rather to promote 
knowledge associated with it. Therefore, policies 
may show partially successful results, even if af-
terward no further processes are carried out by 
which the knowledge produced can contribute to 
the ultimate goal of definitive control (processes 
such as the development of new drugs by labora-
tories or the fine-tuning of new techniques to be 
administered en masse). 
By disassembling “the fight against the 
disease” into concrete actions, we may also see 
how the political rationality of managing limited 
resources on some occasions makes it logical to 
give up the initiatives before the ultimate goal 
has been achieved. In the case of fumigation, for 
instance, the goal of definitive control implies 
maintaining action standards that are difficult to 
meet in the most endemic areas. In that way, the 
decrease in the rates of infection in the last de-
cades and the relative success this implies also 
serves to limit these initiatives; the less important 
the problem is, the more likely it is that the ac-
tions will not be sustained. Consequently, it may 
seem more logical to allocate funds to other more 
urgent problems.    
The final aspects that this article attempts to 
explore are the cultural dimensions that operate 
in the definition of the disease, both on the part 
of those who identify and discuss the disease 
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and those who suffer from it. Thus, even while 
acknowledging the social importance of the 
disease, due to its geographical spread and the 
type of populations it affects, in the use of these 
categories of analysis we must not overlook the re-
ductionist exercise of the dominant urban medical 
discourse that subsumes a complex situation of 
living conditions, cultural diversity and profound 
material deprivation to a single symptom: carrying 
the parasite. The shortage of clean water, the pre-
carious state of housing constructions, the limited 
access to basic health and education services, the 
lack of employment and food, the continued clash 
between indigenous cultures and the ways of life 
of western capitalism, the lack of recognition of 
civil rights and undocumented migrations, among 
other factors, are disguised behind a medical di-
agnosis. Indeed, we could call this a social synec-
doche: representing the whole through a part, so 
that Chagas becomes a way to name these popu-
lations, either to show solidarity with them or to 
identify them as a population that needs only to 
be cured. 
This exercise may be done in a more or less 
critical way, emphasizing the imposition of a bour-
geois and urban medical discourse on a strange 
rural reality, or proposing a strategy for relating to 
diverse social sectors so as to help those sectors 
develop tools that will eventually enable them to 
carry out strategies of protection and control of ad-
verse situations. In any event, this article aims to 
recover both the complexity of the disease and the 
diverse rationalities existing within the perspec-
tives of the actors involved, as a means of under-
standing the depth of the problem of Chagas as it 
is configured, concretely, in the society in which 
it is immersed.  
eNDNOTes
a. Both in its optimistic and fatalistic variants (ac-
cording to the hopes placed in the development 
of this new knowledge), this is the perspective un-
derlying, in general, the news related to scientific 
or medical events that celebrate new knowledge 
as an “advance” against the disease, be this new 
development the identification of a protein or the 
genome of a vector, even if it is not the primary 
vector in the country. An example of this can be 
seen in the article “Gran avance contra el Cha-
gas: logran decodificar el genoma de la vinchuca” 
[Great advance in the fight against Chagas: the ge-
nome of the triatomine bug has been decoded)](4).
b. The chronic stage was first divided by Chagas 
into 4 types: the pseudo-myxedematous, myxe-
dematous, cardiac and nervous types (6). The re-
lationship between the parasite and thyroid dys-
function was reflected in the first name given to 
the disease: “Parasitic Thyroiditis.” 
c. A few years before the discovery of Chagas di-
sease, the Manguinhos Institute, led by Oswaldo 
Cruz, had carried out the campaigns to eradicate 
yellow fever in Rio de Janeiro, thus gaining acade-
mic and political recognition as well as the recog-
nition of civil society (8).  
d. By 1935, the cases in which the presence of 
the parasite in humans had been demonstrated 
microscopically did not reach 50. See Yorke (11), 
cited by Kropf (9 p.246).
e. The relationship between the parasite and goi-
terism was first called into question by the studies 
of Rudolph Kraus in the Institute of Bacteriology of 
Argentina’s National Department of Hygiene (12).
f. Mazza’s works included the identification of the 
first cases in the mid-1920s, the demonstration of 
the existence of the parasite in the region and the 
existence of vectors, the analysis of the natural re-
servoirs of the parasite, the identification of acute 
and chronic cases, the description of the charac-
teristics of each stage, the analysis of diagnostic 
methods and, finally, trials of different treatments 
(without success) (15).
g. The works of Laranja and Nóbrega, from the 
Bambuí Research Center in Brazil, and of Ro-
senbaum and Álvarez, from the Ramos Mejía Hos-
pital in Argentina, were essential in the definition 
of “chronic Chagas cardiomyopathy” (13). 
h. In situations of drug shortages, or even given the 
threat of such shortages, the differences between 
these two groups are significant. While those with 
HIV/AIDS have held protests to demand the public 
provision of drugs be guaranteed, those with Cha-
gas have not become a major actor in the public 
arena when faced with the news of the unavaila-
bility of the drug.   
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